In a pilot double-blind RCT of 29 night shift workers, lemborexant (5 or 10 mg) did not significantly improve daytime sleep duration vs placebo by diary or actigraphy, nor sleep efficiency, quality or insomnia severity. No serious adverse events with lemborexant.
RCTn = 29
Prather et al. Effects of lemborexant vs placebo on total daytime sleep in shift workers: a randomized controlled trial